Sort
15,842 grants matching “pancreatic cancer”
Novel Target(s) in the Radiosensitization of Pancreatic Cancer
$364,128Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2016 · CA
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$364,128Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2014 · CA
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$364,128Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2016 · CA
Novel Target(s) in the Radiosensitization of Pancreatic Cancer
$364,127Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2014 · CA
Novel Strategies for Pancreatic Cancer Treatment
$364,127Michael G Brattain · University Of Nebraska Medical Center · P50 · FY2014 · CA
Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
$364,015William Joseph Murphy · University Of California At Davis · R01 · FY2015 · CA
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
$364,002Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2012 · CA
Dorsal-Ventral Pattern Formation in the Zebrafish Embryo
$363,990Mary C Mullins · University Of Pennsylvania · R01 · FY2009 · GM
Regulation of Pancreatic Oncogenesis by the Gut Microbiome
$363,894George Miller · New York University School Of Medicine · R01 · FY2019 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$363,871James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Novel Approaches for Pancreatic Cancer Therapy
$363,788Columbia University Health Sciences · R01 · FY2005 · CA
Novel Approaches for Pancreatic Cancer Therapy
$363,788Columbia University Health Sciences · R01 · FY2003 · CA
Novel Approaches for Pancreatic Cancer Therapy
$363,788Columbia University Health Sciences · R01 · FY2004 · CA
Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer
$363,676Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$363,672Tracy L McGaha · University Health Network · R01 · FY2023 · CA
Role of acetyl-CoA in linking cancer cell metabolism and epigenetics
$363,669Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2024 · CA
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
$363,660Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2021 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2020 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2021 · CA
Galpha13 and pancreatic cancer progression
$363,556Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2018 · CA
Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer
$363,516Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer
$363,502Michel M Ouellette · University Of Nebraska Medical Center · R01 · FY2019 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$363,351James A Wells · University Of California, San Francisco · R01 · FY2021 · CA
Spacer Enabled Robust Radiation Therapy (SERRT)
$363,340Kai Ding · Johns Hopkins University · R37 · FY2019 · CA
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer
$363,250Bilal Bin Hafeez · University Of Texas Rio Grande Valley · SC1 · FY2021 · GM